Table 1.

Patients’ characteristics.

Patients, n	34
Male, n (%)	25 (73.5)
Age, years	71.5 ± 9.7
Body Weight, kg	63.7 ± 9.2
Serum creatinine, mg/dL	0.94 ± 0.34
Mean creatinine clearance, mL/min	65.7 ± 19.8
Dose of dabigatran
110 mg twice daily, n (%)	22 (64.7)
150 mg twice daily, n (%)	12 (35.3)
CHADS2 score	2.6 ± 1.4
Paroxysmal atrial fibrillation, n (%)	13 (38.2)
Type of proton pump inhibitor
Lansoprazole, n (%)	14 (41.2)
Rabeprazole, n (%)	14 (41.2)
Esomeprazole, n (%)	6 (17.6)